Chemed Co. (NYSE:CHE) EVP Spencer S. Lee sold 3,514 shares of the business’s stock in a transaction that occurred on Monday, February 25th. The stock was sold at an average price of $326.75, for a total transaction of $1,148,199.50. Following the sale, the executive vice president now directly owns 31,710 shares in the company, valued at $10,361,242.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Shares of NYSE CHE opened at $326.49 on Thursday. The company has a market capitalization of $5.20 billion, a PE ratio of 27.37, a PEG ratio of 1.85 and a beta of 1.20. Chemed Co. has a 52-week low of $255.77 and a 52-week high of $335.99. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.11 and a current ratio of 0.83.
Get Chemed alerts:Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, February 20th. The company reported $3.35 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.08. The firm had revenue of $457.51 million for the quarter, compared to the consensus estimate of $460.50 million. Chemed had a net margin of 11.53% and a return on equity of 36.06%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.32 EPS. On average, equities research analysts expect that Chemed Co. will post 12.77 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 22nd. Stockholders of record on Monday, March 4th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, March 1st. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.37%. Chemed’s dividend payout ratio (DPR) is currently 10.06%.
Several hedge funds and other institutional investors have recently modified their holdings of CHE. Bremer Trust National Association acquired a new position in shares of Chemed in the 4th quarter worth approximately $25,000. Executive Wealth Management LLC acquired a new position in shares of Chemed in the 4th quarter worth approximately $27,000. Financial Gravity Companies Inc. acquired a new position in shares of Chemed during the 4th quarter valued at $45,000. First Hawaiian Bank lifted its position in shares of Chemed by 21.3% during the 4th quarter. First Hawaiian Bank now owns 290 shares of the company’s stock valued at $82,000 after acquiring an additional 51 shares during the period. Finally, Enlightenment Research LLC acquired a new position in shares of Chemed during the 4th quarter valued at $85,000. Hedge funds and other institutional investors own 87.51% of the company’s stock.
A number of brokerages have recently issued reports on CHE. Royal Bank of Canada boosted their price target on shares of Chemed from $313.00 to $318.00 and gave the stock a “sector perform” rating in a research report on Monday. Zacks Investment Research upgraded shares of Chemed from a “hold” rating to a “buy” rating and set a $310.00 price target on the stock in a research report on Friday, January 4th.
COPYRIGHT VIOLATION WARNING: “Chemed Co. (CHE) EVP Sells $1,148,199.50 in Stock” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4184873/chemed-co-che-evp-sells-1148199-50-in-stock.html.Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Further Reading: Futures Contract
No comments:
Post a Comment